Boehringer Ingelheim’s weight-loss drug candidate survodutide could also be effective for liver disease metabolic dysfunction-associated steatohepatitis (MASH), if the results of a mid-stage trial are ...

Novo Nordisk's GLP-1 receptor agonist semaglutide has shown efficacy as a treatment for metabolic dysfunction-associated steatohepatitis (MASH) in a phase 3 trial, potentially teeing up US and ...

July 30, 2026 • Sen. Rand Paul is moving to hold Dr. Anthony Fauci in contempt of Congress after he invoked his Fifth Amendment rights. And, the Trump administration has announced a new rule for the ...

NPR's Up First is the news you need to start your day. The three biggest stories of the day, with reporting and analysis from NPR News — in 10 minutes. Available weekdays at 6:30 a.m. ET, with hosts ...

Copyright 2026 The Denver Post. All rights reserved. The use of any content on this website for the purpose of training artificial intelligence systems, algorithms ...